🇺🇸
United States · US · US:49702-255_a9175b83-2200-4bd2-9ee3-52095b5d2657
Tivicay PD
Orange BookUNIISPLATC J05AJ03
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerViiV Healthcare Company
CountryUS (United States)
ATC codeJ05AJ03
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1149702255371 BOTTLE in 1 CARTON (49702-255-37) / 60 TABLET, FOR SUSPENSION in 1 BOTTLE
Annotations
UNII (FDA Substance ID)
1Q1V9V5WYQ
DOLUTEGRAVIR SODIUM
RxCUI 1433867
Orange Book
N213983
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "1Q1V9V5WYQ",
"rxcui": "1433867",
"inchikey": "UGWJRRXTMKRYNK-VSLILLSYSA-M",
"display_name": "DOLUTEGRAVIR SODIUM",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"485bc9db-8665-9f5a-e063-6394a90a7921": {
"match": "brand_token",
"title": "TIVICAY (DOLUTEGRAVIR SODIUM) TABLET, FILM COATED [ST. MARY'S MEDICAL PARK PHARMACY]",
"spl_version": "2",
"published_date": "2026-05-25"
}
},
"productid": "49702-255_a9175b83-2200-4bd2-9ee3-52095b5d2657",
"productndc": "49702-255",
"dosage_form": "TABLET, FOR SUSPENSION",
"orange_book": {
"appl_no": "213983",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "EQ 5MG BASE",
"product_no": "001",
"approval_date": "Jun 12, 2020"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "DOLUTEGRAVIR SODIUM",
"proprietary_name": "Tivicay PD",
"active_ingred_unit": "mg/1",
"application_number": "NDA213983",
"marketing_category": "NDA",
"nonproprietary_name": "dolutegravir sodium",
"start_marketing_date": "20200612",
"active_numerator_strength": "5"
}Related drugs
Other records sharing ATC code J05AJ03.
Access this data programmatically
Query Tivicay PD and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.